Adv Exp Med Biol

1. ARJMAND B, Alavi-Moghadam S, Faraji Z, Aghajanpoor-Pasha M, et al
   The Potential Role of Intestinal Stem Cells and Microbiota for the Treatment of Colorectal Cancer.
   Adv Exp Med Biol. 2024 May 30. doi: 10.1007/5584_2024.
   

   >> Share

   
   

   
   Ann Surg

2. EBBEHOJ AL, Jorgensen LN, Smith HG, Krarup PM, et al
   Current Management of T1 Colon Cancer in Denmark: A Nationwide Cohort Study.
   Ann Surg. 2024 May 27. doi: 10.1097/SLA.0000000000006355.
   

   >> Share

   
   

   
   BMC Cancer

3. WANG X, Guan X, Tong Y, Liang Y, et al
   UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
   BMC Cancer. 2024;24:644.
   

   >> Share

   
   

   
   BMC Gastroenterol

4. SADEGHI A, Salar S, Moghadam PK, Cheraghpour M, et al
   Design and evaluation of a colon cancer mobile application.
   BMC Gastroenterol. 2024;24:185.
   

   >> Share

   
   

   
   Br J Cancer

5. YANG L, Yi J, He W, Kong P, et al
   Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.
   Br J Cancer. 2024 May 25. doi: 10.1038/s41416-024-02673.
   

   >> Share

   
   
6. MENG XN, Ma JF, Liu YH, Li SQ, et al
   Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
   Br J Cancer. 2024;130:1819-1827.
   

   >> Share

   
   
7. KISAKOL B, Matveeva A, Salvucci M, Kel A, et al
   Identification of unique rectal cancer-specific subtypes.
   Br J Cancer. 2024;130:1809-1818.
   

   >> Share

   
   

   
   Cancer

8. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
   A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
   Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
   

   >> Share

   
   

   
   Clin Cancer Res

9. FUSCO MJ, Casak SJ, Mushti SL, Cheng J, et al
   FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.
   Clin Cancer Res. 2024 May 29. doi: 10.1158/1078-0432.CCR-24-0281.
   

   >> Share

   
   

   
   Clin Med Insights Oncol

10. BENMOKHTAR S, Laraqui A, Hilali F, Bajjou T, et al
    RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review.
    Clin Med Insights Oncol. 2024;18:11795549241255651.
    

    >> Share

    
    

    
    Eur J Cancer

11. TAIEB J, Basile D, Seligmann J, Argiles G, et al
    Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.
    Eur J Cancer. 2024;206:114118.
    

    >> Share

    
    

    
    Eur J Surg Oncol

12. AZLAN A, Rafaqat Z, Ahmad A
    Improving machine learning predictions for metastases in colorectal cancer.
    Eur J Surg Oncol. 2024 May 25:108440. doi: 10.1016/j.ejso.2024.108440.
    

    >> Share

    
    

    
    Gastrointest Endosc

13. LEUNG WK, Tsui VWM, Mak LL, Cheung MK, et al
    Blue-light imaging or narrow-band imaging for proximal colonic lesions: a prospective randomized tandem colonoscopy study.
    Gastrointest Endosc. 2023;98:813-821.
    

    >> Share

    
    
14. KHAN AA, Sarmini MT, Bell R, El Halabi J, et al
    Frequency of endoscopic photodocumentation of large colorectal polyps.
    Gastrointest Endosc. 2023;98:797-802.
    

    >> Share

    
    

    
    Int J Colorectal Dis

15. WU H, Deng M, Xue D, Guo R, et al
    PD-1/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review.
    Int J Colorectal Dis. 2024;39:83.
    

    >> Share

    
    
16. O'SULLIVAN NJ, Temperley HC, Kyle ET, Sweeney KJ, et al
    Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2024;39:82.
    

    >> Share

    
    
17. TAKAO M, Kawai K, Nakano D, Dejima A, et al
    Recurrence of rectal cancer on the pelvic sidewall after lateral lymph node dissection.
    Int J Colorectal Dis. 2024;39:80.
    

    >> Share

    
    
18. LEE YD, Kim HG, Seo M, Moon SK, et al
    Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Int J Colorectal Dis. 2024;39:78.
    

    >> Share

    
    

    
    J Clin Oncol

19. BUTT J, Epplein M
    Potent Tool: Helicobacter pylori Treatment to Reduce the Risk of Both Gastric and Colorectal Cancers.
    J Clin Oncol. 2024;42:1865-1867.
    

    >> Share

    
    

    
    Lancet

20. EDERHY S, Demondion P, Ali A, Montravers F, et al
    A right atrial mass and colonic cancer in a patient with Lynch syndrome.
    Lancet. 2024;403:e32.
    

    >> Share

    
    

    
    PLoS One

21. HUANG Z, Hu X, Wei Y, Lai Y, et al
    ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
    PLoS One. 2024;19:e0303909.
    

    >> Share

    
    
22. CHAOUCH MA, Hussain MI, Carneiro da Costa A, Mazzotta A, et al
    Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304031.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share